Systems and methods for piercing blister seals of blister devices in a cartridge of a diagnostic system

The controlled blister piercing method in diagnostic systems ensures reliable fluid flow by using minimal force and independent actuators, addressing deformation issues and reducing costs and test times.

WO2026235686A1PCT designated stage Publication Date: 2026-11-12HEWLETT PACKARD DEVELOPMENT COMPANY LP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/US2025/027997
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-05-06
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Existing blister devices in diagnostic systems face issues with unreliable fluid flow due to inadequate control of piercing methods, leading to deformation and flow restrictions.

Method used

The system employs controlled blister piercing using winged devices actuated at minimal force, with independent actuators or a single piercer for multiple seals, and hard stops to limit travel, ensuring consistent and reliable fluid flow.

Benefits of technology

This approach achieves high delivery efficiency (approximately 95%) with reduced force requirements, enabling smaller product size, lower costs, and faster diagnostic tests.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure US2025027997_12112026_PF_FP_ABST
    Figure US2025027997_12112026_PF_FP_ABST
Patent Text Reader

Abstract

A diagnostic system includes: a cartridge including: one or more chambers and one or more blister devices, each blister device to store a fluid to be dispensed to or from at least one of the one or more chambers, each blister device including two or more blister seals, each blister seal covering a valve opening of the blister device until the blister seal is pierced, and two or more rupturing members, each rupturing member covering one of the two or more blister seals, and an instrument to interface with the cartridge, the instrument including one or more piercing devices, each piercing device to interface with one of the one or more blister devices, each piercing device including a piercing element to interface with the two or more rupturing members, and one or more stoppers to control a piercing depth of the piercing element.
Need to check novelty before this filing date? Find Prior Art

Description

Atty. Dkt. No.: 86357070SYSTEMS AND METHODS FOR PIERCING BLISTER SEALS OF BLISTER DEVICES IN A CARTRIDGE OF A DIAGNOSTIC SYSTEM BACKGROUND

[0001] Diagnostic systems can include single-use or reusable cartridges that are inserted into an instrument. The cartridges may receive a sample, such as a biological sample. Biological samples may contain molecules or particles that are of interest. For example, the molecules may be indicative of disease, illness, genetic abnormalities, etc. Molecular diagnostics may be performed using the cartridge and instrument.SUMMARY

[0002] This disclosure relates to devices and apparatus for detecting or measuring the presence, absence or amount of a nucleic acid of interest (e.g., a target nucleic acid), in a sample containing or suspected of containing the nucleic acid of interest.

[0003] At least one aspect relates to a diagnostic system. The diagnostic system includes a cartridge including: one or more chambers and one or more blister devices, each blister device to store a fluid to be dispensed to or from at least one of the one or more chambers. Each blister device includes: two or more blister seals, each blister seal covering a valve opening of the blister device until the blister seal is pierced, and two or more rupturing members, each rupturing member covering one of the two or more blister seals. The diagnostic system further includes an instrument to interface with the cartridge, the instrument including: one or more piercing devices, each piercing device to interface with one of the one or more blister devices, each piercing device including a piercing element to interface with the two or more rupturing members to cause the two or more rupturing members to pierce the two or more blister seals of the one of the one or more blister devices, and one or more stoppers to control a piercing depth of the piercing element.

[0004] Another aspect relates to a diagnostic system including a cartridge including one or more chambers, and one or more blister devices, each blister device to store a fluid to be dispensed at least one of the one or more chambers, each blister device including: one or more blister seals and one or more rupturing members, each rupturing member covering one of the one or more blister seals. The diagnostic system further includes an instrument to interface with the cartridge, the instrument including: one or more piercing devices, each piercing device to interface with one of the one or more blister devices, each piercing device including a piercingAtty. Dkt. No.: 86357070element to interface with the one or rupturing members to cause the one or more rupturing members to pierce the one or more blister seals of the one of the one or more blister devices, and one or more stoppers to control a piercing depth of the piercing element, and one or more actuators, each actuator to interface with at least one of the one or more piercing devices, and a controller including one or more memory devices storing instructions thereon that, when executed by one or more processors, cause the one or more processors to: actuate at least one of the one or more actuators to cause the at least one of the one or more piercing devices to move toward the one or more blister seals of a corresponding blister device until the one or more stoppers on each of the one or more piercing devices contacts a surface of the corresponding blister device.

[0005] Another aspect relates to a method for piercing one or more blister seals of a blister device of a diagnostic cartridge, the blister device to store a liquid. The method includes: responsive to a determination to dispense the liquid from the blister device, actuating an actuator for a first time, the actuator interfacing with an end of a piercing device, the actuating for the first time moving the piercing device toward a first rupturing member covering a first blister seal of the one or more blister seals of the blister device to cause a piercing element of the piercing device to move the first rupturing member toward the first blister seal, piercing the first blister seal with the first rupturing member based on the actuating of the actuator for the first time, responsive to detecting a stopper of the piercing device contacting a surface of the blister device, actuating the actuator for a second time, the actuating for the second time retracting the piercing device from the first rupturing member, and extracting the liquid from the pierced blister device to a chamber of the cartridge.BRIEF DESCRIPTION OF THE FIGURES

[0006] These and other aspects and features of the present implementations are depicted by way of example in the figures discussed herein. Present implementations can be directed to, but are not limited to, examples depicted in the figures discussed herein. Thus, this disclosure is not limited to any figure or portion thereof depicted or referenced herein, or any aspect described herein with respect to any figures depicted or referenced herein.

[0007] FIG. 1 A depicts a block diagram of a cartridge and an instrument, in accordance with example implementations.Atty. Dkt. No.: 86357070

[0008] FIG. IB depicts a block diagram of a cartridge and an instrument, in accordance with example implementations.

[0009] FIG. 2 depicts a method for piercing one or more blister seals of a blister device of a diagnostic cartridge, in accordance with example implementations.

[0010] FIG. 3A depicts a first side view of a cartridge device, in accordance with example implementations.

[0011] FIG. 3B depicts a second side view of the cartridge device of FIG. 3 A, in accordance with example implementations.

[0012] FIG. 4A depicts a blister device, in accordance with example implementations.

[0013] FIG. 4B depicts a blister device, in accordance with example implementations.

[0014] FIG. 4C depicts the blister device of FIG. 4A or 4B, in accordance with example implementations.

[0015] FIG. 4D depicts the blister device of FIG. 4A or 4B, in accordance with example implementations.

[0016] FIG. 4E depicts the blister device of FIG. 4 A or 4B, in accordance with example implementations.

[0017] FIG. 5A depicts a blister device, in accordance with example implementations.

[0018] FIG. 5B depicts an actuator of the blister device of FIG. 5 A, in accordance with example implementations.

[0019] FIG. 6A depicts a cross-sectional view of a blister device and actuator in a non-actuated position, in accordance with example implementations.

[0020] FIG. 6B depicts a cross-sectional view of a blister device and actuator in an actuated position, in accordance with example implementations.

[0021] FIG. 7A depicts a perspective view of a piercing device, in accordance with example implementations.Atty. Dkt. No.: 86357070

[0022] FIG. 7B depicts a first perspective view of a plurality of the piercing devices of FIG.7A interfacing with a blister device, in accordance with example implementations.

[0023] FIG. 7C depicts a side view of the plurality of the piercing devices of FIG. 7B interfacing with a blister device, in accordance with example implementations.

[0024] FIG. 7D depicts a second perspective view of a plurality of the piercing devices of FIG.7A interfacing with a blister device, in accordance with example implementations.

[0025] FIG. 8 depicts a plurality of piercing devices interfacing with a housing, in accordance with example implementations.

[0026] FIG. 9A depicts a method of opening two valves of a blister device in serial, in accordance with example implementations.

[0027] FIG. 9B depicts a method of opening two valves of a blister device in parallel, in accordance with example implementations.

[0028] FIG. 9C depicts a method of opening a single valve of a blister device, in accordance with example implementations.

[0029] FIG. 10A depicts an illustration of a cartridge and an instrument, in accordance with example implementations.

[0030] FIG. 10B depicts an illustration of a cartridge and an instrument, in accordance with example implementations.

[0031] FIG. 10C depicts an illustration of a cartridge and an instrument, in accordance with example implementations.

[0032] It will be recognized that the figures are schematic representations of examples for purposes of illustration. The figures are provided for the purpose of illustrating example implementations with the explicit understanding that the figures will not be used to limit the scope of the meaning of the claims. Thus, the description is not limited to the examples and / or implementations provided in the drawings.Atty. Dkt. No.: 86357070DETAILED DESCRIPTION

[0033] Diagnostic systems can include single-use or reusable cartridges that are inserted into an instrument. The cartridges may receive a sample, such as a biological sample. Biological samples may contain molecules or particles that are of interest. For example, the molecules may be indicative of disease, illness, genetic abnormalities, etc. Molecular diagnostics may be performed using the cartridge and instrument. During one or more reactions, such as PCR or PCA reactions, various fluids or solutions, such as system buffers, wash buffers, and the like, may be used to facilitate the reactions. These fluids may be stored in blister devices in the cartridge that include seals that can be opened to release the fluid to a desired location, such as a reaction chamber, within the cartridge.

[0034] Currently, blisters or blister devices used as fluid reservoirs may be unable to reliably flow fluid to or from the blister reservoir. This problem may result from inadequate control of a piercing (e.g., opening) method. If the piecing of the blister device is not controlled, the blister material may become deformed and close during fluid flow, thereby causing flow restrictions.

[0035] The systems and methods described herein may control a blister piercing force, location, and depth to enable reliable fluid flow out and into a blister reservoir. The blister opening method may use a winged blister piercing device that is actuated at a minimum force and located independently of the actuation device. The piercer geometry, location, and driving force may allow the piercing depth of the blister seal to be controlled to a specified height. This delivers repeatable blister seal piercing (e.g., opening), allowing reliable fluid flow to and from the blister reservoir.

[0036] In some examples, the systems and methods described herein may utilize independent actuators for each seal that is pierced. Other examples may utilize a single piercer for multiple seals (e.g., upper and lower seals) of a blister. Similarly, one of the piercers may be integrated into the cartridge clamping device. These various examples may help reduce cost and actuation time.

[0037] Advantageously, the systems and methods described herein may utilize a low force to open blisters (e.g., at or around 35 Newtons, less than or equal to 35 N, etc.) relative to existing methods that use greater force (e.g., at or around 100 N). Further, the piercing devices may be configured to open only a blister seal or blister valve and may not automatically dispense liquid from the blister device. The system described herein may further enable instrument designAtty. Dkt. No.: 86357070flexibility with low force actuation and no actuation speed requirements (e.g., enables either motor or pneumatic actuation methods). Further, in a single valve blister device, the force required to extract liquid by crushing blister may be reduced because the valve is already opened.

[0038] Further, hard stops on the piercing device and / or a blister flange can limit travel of the piercing device relative to a blister valve. This may prevent crushing of the valve, which may subsequently increase a risk of reduced or blocked flow of liquid in or out of the blister device. The systems and methods described herein may facilitate high (e.g., approximately 95%) delivery efficiency.

[0039] Additionally, implementing the systems and methods described herein can reduce an instrument cost to an elimination of a need for precise or high force blister opening. Specifically, pneumatic blister opening, as described herein, can enable smaller product size and lower cost. Further, pneumatic blister opening may not require encoded actuation (e.g., which may enable push to stall). Actuators may also be molded to enable a low cost per actuator. Finally, the systems and methods described herein may enable fast valve actuation and liquid dispensing, saving time (e.g., seconds) per diagnostic test performed within the cartridge.

[0040] Referring now to Fig. 1A, a diagnostic system 100A, comprising a cartridge 100 and an instrument 150 is shown, according to an example. The diagnostic system 100A may be configured to detect a nucleic acid of interest. In some examples, the cartridge 100 of the diagnostic system may include a series of zones or chambers that may be defined as cavities. The zones / chambers / cavities may be interconnected via a plurality of channels. The series of cavities / chambers can be individually loaded with reagents. The cavities / chambers can be loaded with the same or with different types of reagents. Loading the cavities / chambers with different types of reagents can permit a multi-step reaction. The reagents / reactants can be disposed in the chambers or blister devices, as will be described herein.

[0041] As shown in FIG. 1A, the cartridge 100 includes one or more chambers. Specifically, FIG. 1 A shows the cartridge 100 including a first chamber 102 and a second chamber 104. The first and second chambers 102 and 104 may house various types of reactions. For example, in some examples, the first chamber 102 may be an extraction chamber configured to house lysing and / or hybridization reactions. A lyse reaction may damage the content of a biologicalAtty. Dkt. No.: 86357070sample inserted into the cartridge 100 to release one or more nucleic acids from the biological sample. The lyse reaction performed in the first chamber 102 may cause the one or more nucleic acids of interest to be released from the biological sample. The lyse reaction may disrupt, or lyse, cells, and / or tissue samples. That is, the biological sample is lysed within at least one of the one or more first chambers 102 to release one or more nucleic acids from the biological sample.

[0042] As used herein, “hybridization” refers to a process where two substantially complementary nucleic acid strands anneal to each other under appropriately stringent conditions to form a duplex or heteroduplex through formation of hydrogen bonds between complementary base pairs. For example, hybridization may refer to the formation of a double strand from two single strands, which can each include a nucleic acid and / or a capture oligonucleotide. Such hybridization may occur within a hybridization chamber, in which a fluid containing a biological sample may be mixed, agitated, etc. Further, the nucleic acids released from the biological sample during lysis may be hybridized to one or more magnetic particles, which facilitates subsequent amplification and detection of the nucleic acids.

[0043] Similarly, in some examples, the second chamber 104 may be configured to house one or more amplification reactions and facilitate detection of amplification reaction products. As used herein, the terms “amplify” or “amplification” with respect to nucleic acid sequences, refer to methods that increase the representation of a population of nucleic acid sequences in a sample. Copies of a particular target nucleic acid sequence generated in vitro in an amplification reaction may be referred to as “amplicons” or “amplification products.” In various examples, amplification products may refer to any products amplified during an amplification reaction. For example, amplification products may include nucleic acids, unquenched fluorophores generated during each replication cycle of the amplification reaction, etc. Amplification may be exponential or linear. A target nucleic acid may be DNA (such as, for example, genomic DNA and complementary DNA (cDNA) or RNA). Amplification reactions that occur in an amplification chamber may include polymerase chain reactions (PCR), pulse controlled amplification (PCA) reactions, and / or numerous other methods such as isothermal methods, rolling circle methods, etc. Such methods may be used either in place of, or together with, PCR methods.

[0044] As described herein, PCA reactions may refer to a type of reaction performed to amplify one or more nucleic acids (e.g., to characterize the presence of a pathogen, such as a virus orAtty. Dkt. No.: 86357070bacteria). PCA reactions may enable rapid thermocycling with a low power expenditure by using paramagnetic particles to concentrate DNA or other nucleic acid targets into a thin thermocycling zone. Additionally, PCA utilizes polymerase chain reaction (PCR) chemistry to replicate and amplify target molecules (e.g., nucleic acids of interest, such as DNA or RNA). The paramagnetic particles may automate and integrate solid-phase extraction of the sample specimen with PCA and a real-time multi-channel detection, thus reducing both a run time of diagnostics and a cost of running the diagnostics.

[0045] During a PCA reaction, a lysate containing a nucleic acid of interest is hybridized to capture oligonucleotides and attach the oligonucleotides and nucleic acid of interest to a plurality of magnetic particles. Hybridization may occur in the first chamber 102. After hybridization, the nucleotides of interest and the capture oligonucleotides may be transported to the second chamber 104. In the second chamber 104, the magnetic particles may be docked to a heating element positioned within the second chamber 104. For example, a magnetic field generator may generate a magnetic field such that the magnetic particles dock to the heating element. The capture oligonucleotides attached to the docked magnetic particles may subsequently undergo elongation to increase a length of the strand or strands of the capture oligonucleotides.

[0046] An electrical pulse may be delivered through the heating element. The electrical pulse may generate heat such that a heating zone having the local reaction liquid is heated to a predefined temperature value. The predefined temperature value may be a denaturation or melting temperature at which the DNA or RNA denatures. The local reaction liquid may be a portion of the total volume of liquid in the second chamber 104. In various examples, the local reaction liquid may be liquid surrounding the magnetic particles, the capture oligonucleotides, the nucleic acids of interest, etc. that undergo a reaction / amplification. During heating of the heating element and the local reaction liquid, the capture oligonucleotides attached to the magnetic particles may denature. As a result, the target oligonucleotides may become free in solution. In various examples, the heating zone may quickly return to an annealing or elongation temperature value from the denaturation temperature value. For example, due to a heat capacity of the second chamber 104, the locally heated area or volume of the second chamber 104 may rapidly decrease.

[0047] Primers may then bind to single strand oligonucleotides on the magnetic particles (e.g., the primers anneal to the denatured oligonucleotides). The primers are short, single- strandedAtty. Dkt. No.: 86357070segments of nucleic acid (e.g., DNA) that are designed to be complementary to the beginning and / or end of the target sequence that will be amplified (e.g., the nucleic acid of interest). During the amplification / elongation step of the PCR, the primers may bind to the nucleic acid of interest (e.g., the DNA sequence of interest) on each end of the sequence of interest that is to be amplified (e.g., the target nucleic acid is “bookended” by the primers). Enzymes (e.g., DNA polymerase) may copy the part of the target oligonucleotide sequence that falls between the primers, selectively amplifying the sequence of interest. In various examples, the capture oligonucleotide may also be used as a primer.

[0048] The strand of the primers and the oligonucleotides may then be elongated. For example, polymerase may elongate the strand. Elongation of the single strand into a double strand may occur between forward and reverse primers attached to the double strand in the annealing step. Thus, elongation may occur between the forward primer and the capture oligonucleotide (which also functions as the reverse primer). During elongation, fluorophores may be released into the solution for detection of the amplified nucleic acids of interest. For example, Taqman probes may be used to release fluorophores into the solution. An optical unit of the instrument 150 may detect the fluorophores to determine a corresponding value, absence, presence, etc. of the amplified nucleic acid of interest.

[0049] The processes described above may be repeated. For example, after the strand has been elongated, another electrical pulse may occur. Thus, more oligonucleotides are again denatured, and the process may repeat to generate a plurality of the nucleic acids of interest, for example, a certain number of times. The number of times may be a predetermined number or may depend upon a number of amplified strands.

[0050] The cartridge 100 may also include one or more reagents. The reagents may be located in various locations throughout the cartridge 100. For example, the reagents may be stored in one or both of the first chamber 102 and the second chamber 104. In various other examples, no reagent may be stored in any chamber, but may be stored elsewhere in the cartridge 100. For example, the reagents may not reside in any extraction or detection chambers, but may be stored in other locations of the cartridge 100. Liquid reagents may include, for example, wash buffers, system buffer or compositions, PCA buffers, etc.

[0051] A wash buffer refers to a buffer used for washing magnetic particles and one or more chambers of the cartridge 100. In some examples, the wash buffer can comprise water, a salt,Atty. Dkt. No.: 86357070a buffering compound or component (e.g., tris buffer) and / or a surfactant. The cartridge 100 may store multiple wash buffers (e.g., first and second wash buffers) in multiple blister devices 106 (e.g.,. a first blister device 106a and a second blister device 106b, respectively).

[0052] A system composition may be a buffer or composition useful for lysis and hybridization of a sample (e.g., a biological sample). The system composition may also be referred to as a “system buffer.” The system composition may include ingredients (e.g., a buffer) to control a pH of the solution. In some examples, the system composition can comprise water, a salt and / or a surfactant. The system composition may also include a buffering component to buffer the pH of the solution. For example, the buffering component may be a tris buffer.

[0053] A PCA buffer may refer to a buffer used to reconstitute a master mix reagent used for reverse transcription and PCA amplification. In some examples, a PCA buffer comprises water, a salt, a buffer compound (e.g., tris buffer) and optionally a surfactant. The master mix reagent may be used during amplification for reverse transcription and / or amplification and real-time detection of nucleic acids of interest.

[0054] In various examples, liquid reagents or other system compositions may be stored in blister devices 106 of the cartridge 100. As such, the cartridge 100 may include one or more blister devices 106. Specifically, FIG. 1 A depicts a first blister device 106a and a second blister device 106b included in the cartridge 100 (e.g., individually, blister device 106, and together, blister devices 106). Each blister device 106 may store a fluid (e.g., liquid reagent) that is to be dispensed to and / or from at least one of the one or more chambers. For example, a blister device 106 may store a wash buffer that is to be transported from the blister device 106 to the first chamber 102. In some examples, upon use of the wash buffer in the first chamber 102, the wash buffer may be transported back into the blister device 106 in which the wash buffer was originally stored. In some examples, the blister devices 106 may be metal -lined blister devices.

[0055] Each of the first and second blister devices 106a and 106b may include two or more blister seals. As shown in FIG. 1A, the first blister device 106a and the second blister device 106b each include a first blister seal 108a and a second blister seal 108b (e.g., individually, blister seal 108, and together, blister seals 108). Each blister seal 108 may cover a valve opening of the blister device 106. Each blister seal 108 may be, for example, a plastic film. As will be described in greater detail herein, each blister seal 108 may be pierced by a rupturing member 110 to open the blister seal 108 and permit fluid to enter and / or exit the blister deviceAtty. Dkt. No.: 86357070106. Each blister seal 108 of a blister device 106 may therefore cover a valve opening until the blister seal 108 is pierced.

[0056] Each of the first and second blister devices 106a and 106b may further include two or more rupturing members 110. As shown in FIG. 1 A, the first blister device 106a and the second blister device 106b may respectively include a first rupturing member 110a and a second rupturing member 110b (e.g., individually, rupturing member 110, and together, rupturing members 110). As will be described in greater detail herein, each rupturing member 110 may pierce a corresponding blister seal 108 of the blister device 106. For example, a rupturing member 110 may be formed as part of the blister device 106. The rupturing member 110 may be positioned proximate a location of a blister seal 108. For example, each rupturing member 110a and 110b of the blister device 106 covers a corresponding blister seal 108 (e.g., the first rupturing member 110a covers the first blister seal 108a and the second rupturing member 110b covers the second blister seal 108b). Each rupturing member 110 may interface with a piercing element of a piercing device. The piercing device may be actuated to cause the piercing element to interface with the rupturing member 110 to cause the rupturing member 110 to pierce the blister seal 108 of the blister device 106. That is, the piercing element 156 is actuated to push the rupturing member 110 toward the blister seal 108 until the rupturing member 110 ruptures (e.g., opens, pierces, etc.) the blister seal 108. Upon piercing the blister seal 108, fluid is permitted to enter and / or exit the blister device 106. The rupturing member 110 may be actuated by the piercing element such that the rupturing member 110 is not over actuated to cause fluid to be prevented from exiting the blister device 106.

[0057] Referring still to FIG. 1A, the instrument 150 is shown, according to some examples. The diagnostic system 100A may include the instrument 150 to interface with (e.g., connect to) the cartridge 100. The cartridge 100 may be inserted into the instrument 150 to perform the processes described herein. In various examples, the cartridge 100 may be a single use cartridge. For example, one cartridge may be used one time to detect the presence of nucleic acids in one biological sample.

[0058] The instrument 150 may include one or more piercing devices 152. Specifically, FIG.1A depicts a first piercing device 152a and a second piercing device 152b (e.g., individually, piercing device 152, and together, piercing devices 152). Each piercing device 152 may interface with one of the one or more blister devices 106 of the cartridge 100. For example, the first piercing device 152 may interface with the first blister device 106a and the second piercingAtty. Dkt. No.: 86357070device 152b may interface with the second blister device 106b. The piecing devices 152 may interface with corresponding blister device 106 upon complete insertion of the cartridge 100 into the instrument 150.

[0059] As shown in FIG. 1A, each piercing device 152 may include a piercing element 156 and one or more stoppers 154, shown in FIG. 1 A as first stopper 154a and second stopper 154b (e.g., individually, stopper 154, and together, stoppers 154). The piercing element 156 may be configured to interface with the rupturing members 110 of each of the one or more blister devices 106 (e.g., the two or more rupturing members and / or the one or more rupturing members). As such, the piercing element 156 may interface with the one or rupturing members 110 to cause the one or more rupturing members 110 to pierce the one or more blister seals 108 of the one of the one or more blister device 106. As described herein, the two or more rupturing members 110 may pierce the two or more blister seals 108 of each of the one or more blister devices 106 of the cartridge 100. For example, the first piercing device 152 may be generally positioned proximate the first blister device 106a. As will be described herein, each piercing device 152 may move positions to interface with the first rupturing member 110a, causing the first rupturing member 110a to pierce the first blister seal 108a of the blister device 106, and to interface with the second rupturing member 110b, causing the second rupturing member 110b to pierce the second blister seal 108b of the blister device 106. The one or more stoppers 154 may control a piercing depth of the piercing element 156. In this manner, a piercing depth of the piercing device 152 may regulated to cause repeatable piercing of any blister seal 108 by the rupturing member 110. That is, the one or more stoppers 154 may cause the rupturing members 110 to move toward the blister seals 108 by a certain, standard amount, so that each blister seal 108 is opened the same amount.

[0060] In various examples, multiple piercing devices 152 may be configured to pierce the blister seals 108 of the blister device 106. For example, a number of piercing devices 152 associated with a blister device 106 may correlate with a number of rupturing members 110 of the blister device, and a number of rupturing members 110 may correlate with a number of blister seals 108 of the blister device. For example, a blister device 106 having two rupturing members 110 and two blister seals 108 may have two piercing devices 152 that interface with the blister device 106. A first piercing device 152a may interface with a first rupturing member 110 to cause the first rupturing member 110a to pierce a first blister seal 108a and a second piercing device 152b may interface with a second rupturing member 110b to cause the secondAtty. Dkt. No.: 86357070rupturing member 110b to pierce a second blister seal 108b. In other examples, each piercing device 152 may have a corresponding blister device 106. The piercing device 152 can be actuated or moved to interface with any number of rupturing members 110 such that one piercing device 152 can cause any number of rupturing members 110 to move to cause a blister seal 108 corresponding to that rupturing member 110 to be pierced.

[0061] As such, in some examples, and as shown in FIG. 1A, the instrument 150 includes a first piercing device 152a and a second piercing device 152b. The first and second piercing devices 152a and 152b are configured to move a first rupturing member 110a and a second rupturing member 110b, respectively, to cause the first rupturing member 110a and the second rupturing member 110b pierce a first blister seal 108a and a second blister seal 108b, respectively, of one of the one or more blister devices 106 (e.g., the first blister device 106a). In various examples, the first and second piercing devices 152a and 152b may cause the rupturing members 110a and 110b to move in sequence, such that the rupturing members 110a and 110b may pierce the first and second blister seals 108a and 108b in sequence (e.g., the first blister seal 108 is pierced and the second blister seal 108b is subsequently pierced, or vice versa). In other examples, the first and second piercing devices 152a and 152b may cause the first and second rupturing members 110a and 110b to move in parallel, such that the first and second rupturing members 110a and 110b pierce the first and second blister seals 108a and 108b in parallel (e.g., the first blister seal 108 is pierced at the same time or substantially the same time as the second blister seal 108b is pierced).

[0062] In some examples, the instrument 150 may further include one or more actuators, as will be described and shown with respect to FIG. IB. The one or more actuators may actuate the one or more piercing devices 152 to and from the one or more blister devices 106. The piercing element 156 may move each rupturing member 110 by delivering a force less than or equal to, for example, 35 Newtons (N) to each of the two or more rupturing members 110. This may cause each rupturing member 110 to pierce each of the two or more blister seals 108 by delivering a force less than or equal to, for example, 35 N. In various examples, the piercing element 156 may deliver any amount of force that prevents the blister seal 108 from becoming crushed or disfigured such that fluid flow in and out of the blister device 106 is prevented. As such, in various examples, the piercing element 156 may move each rupturing member 110 with a force less than or equal to a certain value (e.g., 35 N) to cause each rupturing member 110 to pierce a blister seal 108 with a force less than or equal to a certain value (e.g., 35 N).Atty. Dkt. No.: 86357070

[0063] A geometry of the piercing element 156 may match (e.g., be complementary to) a geometry of a corresponding rupturing member 110 of a blister device 106. For example, the piercing element 156 may be a semispherical, convex protuberance of the piercing device 152. The rupturing member 110 may be a semispherical, concavity of the blister device 106. The radius, surface area, arc, angle, etc. of the piercing element 156 may match, be the same as, similar to, complementary to, etc., the radius, surface area, arc, angle, etc. of the corresponding rupturing member 110 such that the piercing element 156 fits with the rupturing member 110. The piercing element 156 may move each of the two or more rupturing members 110 of a blister device 106 to cause the two or more rupturing members 110 to pierce the two or more blister seals 108 of the blister device 106 such that fluid (e.g., a liquid reagent) is dispensed from the blister device 106. That is, the piercing device 152 may be actuated to cause the two or more rupturing members 110 to pierce the two or more blister seals 108 such that fluid is dispensed from the one of the one or more blister devices. The fluid may be dispensed from the blister device 106 only upon actuating (e.g., piercing, opening) the blister seal 108.

[0064] As shown in FIG. 1A, the one or more stoppers 154 of each piercing device 152 may be positioned on a first end of the piercing device 152. The first end of each piercing device 152 may be positioned to interface with a cavity of a housing of the instrument 150, as will be shown in greater detail with respect to FIG. 8. Interfacing with the cavity of the housing (e.g., a cavity 804, described with respect to FIG. 8) may guide the piercing device 152 to a corresponding blister device 106.

[0065] In some examples, the instrument 150 may further include a lyse system. The lyse system may interface with at least one of the one or more first chambers 102 of the cartridge 100. The lyse system may include a sonicator, which may interface with the at first chamber 102. The lyse system may be utilized when lysing a biological sample occurs. The lyse system may include sonication (e.g., use of ultrasonic energy), thermal lysis, and / or thermal sonication system. In some examples, the lyse system may include a heating system.

[0066] In some examples, the lyse system is programmable. Thus, a user may be able to control, set, determine, etc. lysing protocol parameters (e.g., using a controller 160), such as the sample volume, sonication power level, acoustic frequency, and lysing duration. The lyse system may also provide a cooling feature, enabled by a heat exchanging sub-assembly, which may prevent the biological sample from exceeding a maximum set temperature during operation.Atty. Dkt. No.: 86357070

[0067] The instrument 150 may include a magnetic field generator to generate a magnetic field. The magnetic field may be used to dock a plurality of magnetic particles to at least one zone of the plurality of zones of the cartridge 100. In various examples, the magnetic field generator is a magnet (e.g., a permanent magnet). The magnetic field generator may be positioned at or proximate the second chamber 104 (e.g., a detection chamber). The magnetic field generator may be configured to generate a magnetic field such that the magnetic particles that are hybridized with the nucleic acid of interest and / or the capture oligonucleotides are separated from the lysate solution such that a PCA reaction can occur. The magnetic field generator may be a current carrying conductor or other device that may be powered on or activated such that electric charges being moving to create the magnetic field. In various embodiments, the instrument 150 may be activated or powered on to activate the magnetic field generator.

[0068] In some examples, the magnetic field generator is configured to generate a variable magnetic field in such a manner that acts on at least a part of the magnetic particles present in the detection chamber and that are linked to the nucleic acid of interest.

[0069] The instrument 150 may include one or more cartridge-contact heaters. The cartridgecontact heater may be a heater configured to heat one or more components, zones, etc. of the cartridge 100. For example, the cartridge-contact heater may heat the first chamber 102 during lysing of the biological sample with the system composition and an internal positive control (IPC). The cartridge-contact heater may also be used to heat the lysate during hybridization.

[0070] The instrument 150 may include electrical components. The electrical components may provide an electrical connection between the instrument 150 and one or more zones, chambers, components, etc. of the cartridge 100. For example, the electrical components may provide an electrical connection between the instrument 150 and the cartridge 100 to activate the one or more heating elements of each of the one or more second chambers 104. An interaction of the second chamber 104 and the electrical components, via an electrical connection, may provide heat modulation to amplify the one or more nucleic acids of interest that have been hybridized to the capture oligonucleotides of the plurality of magnetic particles. The electrical components may provide a connection to the heating element in the detection chamber.

[0071] The instrument 150 may include an optical unit. The optical unit may be coupled with at least one of the chambers 102 or 104. The optical unit may be configured to detect a presence, absence, amount, etc. of the nucleic acid of interest after amplification has been performed. InAtty. Dkt. No.: 86357070various examples, the optical unit is to detect a plurality of amplification products indicative of a presence, absence, or amount of the amplified one or more nucleic acids of interest. The optical unit may detect the nucleic acid via a label bound to the nucleic acid of interest during amplification.

[0072] In various examples, the cartridge 100 may include a transparent window in at least one chamber (e.g., the second chamber 104) to allow the optical unit to detect a plurality of amplification products indicative of a presence, absence, or amount of the plurality of amplified nucleic acids of interest. The transparent window may permit light from the optical unit to pass through the cartridge 100 so that light can enter a detection chamber and detect the amplification products indicative of a presence, absence, or amount of the plurality of amplified nucleic acids of interest.

[0073] The instrument 150 may also include a plurality of sensors detect fluid movement throughout the cartridge 100. The sensors may detect fluid movement via, for example, reflection. The sensors may be capacitive sensors configured to detect a dielectric property in the plurality of detection chambers 120 and / or one or more of the plurality of zones. In various examples, the sensors may be or include optical sensors configured to detect a dielectric property in one of more of the plurality of chambers and / or one or more of the plurality of zones.

[0074] Referring now to FIG. IB, a diagnostic system 100B is shown, according to an example. The diagnostic system 100A includes a cartridge 100 and an instrument 150. The cartridge 100 and the instrument 150 may include the same or similar elements as the elements found in the cartridge and instrument of the diagnostic system 100A. For example, first and second chambers 102, the first and second blister devices 106, and the first and second piercing devices 152 may be the same as those described with respect to FIG. 1A.

[0075] In addition to the elements described above with respect to FIG. 1 A, the instrument 150 of the diagnostic system 100B includes one or more actuators 158, shown as a first actuator 158a and a second actuator 158b, and a controller 160.

[0076] Each actuator 158 interfaces with at least one of the one or more piercing devices 152. For example, the first actuator 158a may interface with the first piercing device 152a and the second actuator 158b may interface with the second piercing device 152b. As such, in some examples, a first piercing device 152a may be coupled to a first actuator 158a and a secondAtty. Dkt. No.: 86357070piercing device 152b may be coupled to a second actuator 158b. The first and second piercing devices 152 may be configured to interface with a first rupturing member 110a and a second rupturing member 110b, of a blister device 106 (e.g., the blister device 106a) to cause the first rupturing member 110a and the second rupturing member 110b pierce a first blister seal 108a and a second blister seal 108b, respectively, of a blister device (e.g., the first blister device 106a). As will be described herein, the actuators 158 may cause the piercing devices 152 to be actuated toward the blister device(s) 106. A piercing element 156 of the piercing device 152 may move toward a rupturing member 110 of the blister device 106. Due to the matching geometries of the piercing element 156 and the rupturing member 110, the rupturing member 110 may receive the piercing element 156. As the piercing device 152 is moved toward the blister device 106, and while the piercing element 156 is received by the rupturing member 110, the piercing element 156 may cause the rupturing member 110 to move in the same directed. As such, actuation of the piecing device 152 causes the rupturing member 110 to move toward a corresponding blister seal 108 (e.g., until the stoppers 154 interface with a surface of the blister device 106) and pierce the blister seal 108.

[0077] The controller 160 may include one or more memory devices and one or more processors. The memory devices may store instructions that are executed by the one or more processors to perform one or more actions. For example, the controller 160 may be electrically and / or otherwise communicably coupled to the first and second actuators 158. As such, the controller 160 may actuate at least one of the one or more actuators 158. Actuating the actuators 158 may cause the piercing devices 152 to move toward at least one rupturing member 110 of a corresponding blister device 106. The piercing device 152 may be actuated toward the one or more rupturing members 110 of a corresponding blister device 106 until the one or more stoppers 154 on each of the one or more piercing devices 152 contacts a surface of the corresponding blister device 106. The rupturing member 110 may contact and pierce a blister seal 108.

[0078] The controller 160 may cause a first actuator 158a to actuate the first piercing device 152a toward the first rupturing member 110a. Further, the controller 160 may cause a second actuator 158b to actuate the second piercing device 152b toward the second rupturing member 110b in parallel with the actuation of the first actuator 158a.

[0079] Contact of the stoppers 154 with a surface of the blister device 106 may indicate that the piercing device 152 cannot be actuated further toward the blister device. Further, stoppingAtty. Dkt. No.: 86357070actuation of the piercing device 152 upon contact may ensure that every blister seal 108 is pierced by a rupturing member 110 the same amount or with the same depth, thereby ensuring consistency among blister devices 106 and piercing devices 152.

[0080] In some examples, the controller 160 may determine that the rupturing member 110 has pierced a blister seal 108 (e.g., based on a determination or indication that the stoppers 154 have contacted a surface of the blister device 106, based on an indication of resistance of the piercing device 152 to moving forward, based on a determination that the piercing device 152 and / or the rupturing member 110 has traveled a predefined distance, etc.). Responsive to the determination, the controller 160 may actuate at least one of the actuators 158 to cause the piercing device 152 to move away from the blister seal 108 of the blister device 106 that has just been pierced.

[0081] In various examples, the controller 160 may cause the piercing device 152 to move toward the rupturing member 110 using a certain force (e.g., 35 N, less than or equal to 35N, etc.). This may cause the rupturing member 110 to move toward the blister seal 108 and / or pierce the blister seal 108 using the same force or a similar force. The controller 160 may determine that the rupturing member 110 has not pierced the blister seal 108 (e.g., based on an indication that fluid has not exited the blister device 106, etc.). Responsive to the determination, the controller 160 may actuate the actuator 158 to cause the corresponding piercing device 152 to move toward the rupturing member 110 using a second force, thereby causing the rupturing member 110 to move toward the blister seal 108 and / or pierce the blister seal 108 using a second force. The second force may be greater than the first force. For example, the first force may be 35 N and the second force may be 40 N.

[0082] The controller 160 may cause the first and second actuators 158a and 158b to actuate the first and second piercing devices 152a and 152b in series or in parallel. For example, the controller 160 may cause the first actuator 158a to actuate the first piercing device 152a toward a first rupturing member 110a during a first time period, thereby causing the first rupturing member 110a to move or actuate toward, and pierce, a first blister seal 108a during the first time period. The controller 160 may cause the second actuator 158b to actuate the second piercing device 152b toward a second rupturing member 110b during the first time period, thereby causing the second rupturing member 110b to move or actuate toward, and pierce, a second blister seal 108b such that the blister seals 108 are opened at the same time or substantially the same time (e.g., in parallel).Atty. Dkt. No.: 86357070

[0083] In other examples, the controller 160 may cause the first actuator 158a to actuate the first piercing device 152a toward a first rupturing member 110a during a first time period. This may cause the first rupturing member 110a to move toward and / or pierce a first blister seal 108a during the first time period. The controller 160 may cause the second actuator 158b to actuate the second piercing device 152b toward a second rupturing member 110b during a second time period that occurs after the first time period. This may cause the second rupturing member 110b to move toward and / or pierce a second blister seal 108b during the second time period that occurs after the first time period, such that the blister seals 108 are opened in succession (e.g., in series).

[0084] In some examples, a single piercing device 152 may interface with all rupturing members 110 of a blister device 106. Responsive to a determination by the controller 160 that one or more stoppers 154a of a piercing device 152 contacts a surface of the corresponding blister device 106 surrounding the first rupturing member 110a and / or the first blister seal 108a, the controller 160 may actuate the actuators 158 to cause the piercing device 152 to move from a location corresponding to the first rupturing member 110 toward a location corresponding to the second rupturing member 110b. The controller 160 may then actuate the actuator 158 to cause the piercing device 152 to move toward the second rupturing member 110b until the one or more stoppers 154 on the piercing device 152 contacts a surface of the corresponding blister device 106 surrounding the second rupturing member 110b and / or the second blister seal 108b.

[0085] Referring now to FIG. 2, a method 200 for piercing one or more blister seals of a blister device of a diagnostic cartridge is shown, according to an example. As described above, the blister device 106 may store a liquid (e.g., a liquid reagent such as wash buffer, system buffer, etc.).

[0086] In some examples, prior to process 202 (e.g., the start of the method 200), the controller 160 may determine that liquid is to be dispensed from the blister device 106. For example, upon insertion of the cartridge 100 into the instrument 150, the controller 160 may receive a signal or indication that a liquid is to exit a blister device 106.

[0087] At process 202, responsive to a determination to dispense the liquid from the blister device 106 (e.g., as described above), the controller 160 may actuate an actuator 158 for a first time. The actuator 158 may interface with an end of a piercing device 152. Actuating the actuator 158 for the first time may include moving the piercing device 152 toward a firstAtty. Dkt. No.: 86357070rupturing member 110a of one or more rupturing members 110 of the blister device 106. The first rupturing member 110a may cover a first blister seal 108a of the one or more blister seals 108 of the blister device 106. Actuating the actuator 158 for the first time may cause a piercing element 156 of the piercing device 152 to move the first rupturing member 110a toward the first blister seal 108a. In some examples, actuating for the first time moves the piercing device 152 toward the first rupturing member 110a using a first force (e.g., 35 N). Similarly, actuating for the first time moves the rupturing member 110a toward and / or pierces the blister seal 108a using the first force.

[0088] At process 204, the first rupturing member 110a pierces the first blister seal 108a. The first rupturing member 110a may pierce the first blister seal 108a based on the actuating of the actuator 158 for the first time (e.g., such that the piercing device 152 moved towards and interfaces with the first rupturing member 110a, thereby causing the first rupturing member 110a to move toward and pierce the first blister seal 108a).

[0089] In some examples, the method 200 includes determining, by the controller 160, that the first rupturing member 110a has not pierced the first blister seal 108a. Responsive to the determination, the controller 160 may actuate the actuator 158 for a second time to cause the piercing device 152 to move toward the first rupturing member 110a using a second force. The second force may be greater than the first force. This may cause the first rupturing member 110a to move toward and / or pierce the first blister seal 108a of the corresponding blister device 106 using the second force.

[0090] In some examples, the actuator 158 is a first actuator 158a and the piercing device 152 is a first piercing device 152a. The method 200 may further include actuating, using a second actuator 158b, a second piercing device 152b toward a second rupturing member 110b of the blister device 106 while the actuating the first actuator 158 to move the first piercing device 152a toward the first rupturing member 110a. Similarly, the second rupturing member 110b may be moved toward and / or pierce a second blister seal 108a of the one or more blister seals 108 while the first rupturing member 110a moves toward and / or pierces the first blister seal 108a. The second piercing device 152 may be actuated, using the second actuator 158b, toward the second rupturing member 110b in parallel with the actuation of the first actuator 158a.

[0091] In other examples, the actuator 158 is a first actuator 158a and the piercing device 152 is a first piercing device 152a. The method 200 may further include actuating, using a secondAtty. Dkt. No.: 86357070actuator 168b, a second piercing device 152b toward a second rupturing member 110b of the blister device 106 subsequent to actuating the first actuator 158a to move the first piercing device 152a toward the first rupturing member 110a. Similarly, the method 200 may further include actuating or moving the second rupturing member 110b of the blister device 106 toward and / or piercing a second blister seal 108b subsequent to actuating or moving the first rupturing member 110a toward and / or piercing the first blister seal 108a.

[0092] At process 206, responsive to detecting, by the controller 160, that a stopper 154 of the piercing device 152 contacts a surface of the blister device 106, the controller 160 may actuate the actuator 158 for a second time. Actuating for the second time may retract the piercing device 152 from the first rupturing member 110a.

[0093] In some examples, responsive to actuating the actuator 158 for a second time, the controller 160 may actuate the actuator 158 for a third time. Actuating the actuator 158 for the third time may move the actuator 158 from a location corresponding to the first rupturing member 110a to a location corresponding to a second rupturing member 110b of the blister device 106.

[0094] The method 200 may then further include actuating, by the controller 160, the actuator 158 for a fourth time. Actuating for the fourth time may move the piercing device 152 toward the second rupturing member 110b of the blister device 106 to cause a piercing element 156 of the piercing device 152 to move the second rupturing member 110b toward a second blister seal 108b. The method 200 may then include piercing the second blister seal 108b with the second rupturing member 110b based on actuating the actuator 158 for the fourth time. Responsive to detecting the stopper 154 of the piercing device 152 contacts a surface of the blister device 106, the controller 160 may actuate the actuator 158 for a fifth time. Actuating for the fifth time may include retracting the piercing device 152 from the second rupturing member 110b.

[0095] At process 208, the liquid may be extracted from the pierced blister device 106. The liquid may be extracted to a chamber (e.g., chamber 102 or chamber 104) of the cartridge 100. The liquid may be extracted by, for example, squeezing the blister device, crushing the blister device, opening blister valves and applying air pressure, etc.).

[0096] Referring now to FIG. 3A, a side view of an example cartridge 300A device is shown, in accordance with present examples. The cartridge 300 A may be the same as or similar to theAtty. Dkt. No.: 86357070cartridge 100 of FIGS. 1 A and IB. The side view of the cartridge 300A may show a side of the cartridge that interfaces with the instrument 150. As shown, the cartridge 300A may include a sample input cover 303, a sample input port 305, a first chamber 102, a second chamber 104, a third chamber 310, and a fourth chamber 312.

[0097] In some examples, the first chamber 102 is a hybridization and lyse chamber, the second chamber 104 is an amplification chamber, the third chamber 310 is a waste storage chamber, and the forth chamber 312 is an overflow chamber. As such, the first chamber 102 may be configured to house lysis and / or hybridization processes (e.g., where a biological sample is lysed to release nucleic acids and the nucleic acid strands are hybridized to magnetic particles), and the second chamber 104 may be configured to house an amplification reaction (e.g., a PCA reaction of the hybridized nucleic acid strands) and / or detection of the amplified nucleic acid strands. The third chamber 310 may store waste (e.g., fluids, reagents, buffer solutions, etc.) that has been used and is no longer needed in the cartridge to perform any reactions or processes. The fourth chamber 312 may store additional (e.g., overflow) fluids, such as wash buffers. Each of the chambers may receive fluids from one or more blister devices 106 (described in greater detail with respect to FIG. 3B). For example, a first chamber 102 may receive a system composition from a first blister device 106a (e.g., via one or more pumps configured to pump the fluid out of the blister device, through one or more channels), and into the desired chamber. After using the system composition in the chamber, the system composition may be removed from the first chamber 102, and one ore more pumps may pump the fluid out of the chamber, through one or more channels, and back into the first blister device 106a.

[0098] As described with respect to FIGS. 1 A and IB, the cartridge may house a plurality of reactions, such as lyse reactions, hybridization reactions, amplification reactions, etc., and detect products resulting from amplification reactions. For example, biological sample containing one or more nucleic acids of interest may undergo a plurality of reactions to ultimately detect the presence, absence, and / or amount of the nucleic acids of interest within the biological sample.

[0099] The sample input port 305 may be a port or cavity coupled with a sample input chamber. The sample input port 305 may receive the biological sample and direct the sample into the sample input chamber.Atty. Dkt. No.: 86357070

[0100] The sample input cover 303 may be a cover that interfaces with the sample input port 305. The sample input cover 303 may seal the sample input chamber by preventing liquid from exiting the sample input chamber through the sample input port 305. The sample input chamber may receive a biological sample or other fluid containing one or more nucleic acids of interest. Thus, the cartridge 300 A may include one or more sample fill indicators to indicate a fill level of the sample input chamber. The sample fill indicators may be lines, tick marks, or other visual indicators of a volume of liquid or fluid in the sample input chamber. The sample input chamber may include a transparent material to view a volume of fluid in the sample input chamber. In some examples, the sample input cover 303 may be a cap (e.g., as shown in FIGS 3A and 3B).The cap may be hinged to flip or rotate to open and close, thereby covering and uncovering the sample input port 305. In some examples, the sample input cover 303 may be configured as a slider to slide along an axis to cover and uncover the sample input port 305.

[0101] Any of the chambers 102, 104, 310, and / or 312 may be connected (e.g., coupled, fluidically coupled, etc.) via one or more channels. The channels may be fluidly coupled via a plurality of fluidic junctions. Transport of fluid through the cartridge 300A may be moderated by a plurality of valves. For example, the cartridge 300 A may include a plurality of pinch valves, membrane valves, etc. configured to selectively permit and restrict flow through the fluidic channels. For example, when a valve is closed, fluid movement may be restricted. The fluidic channels may permit fluid flow from one of the plurality of zones and / or chambers to another zone and / or chamber. For example, fluid may flow from the extraction zone or an extraction chamber to a detection zone or detection chambers. In various examples, the instrument 150 may include a pump to interface with the cartridge 300A, specifically the fluid channels of the cartridge 100, to pump air to move air and the fluid through the channels. In various examples, a pressure differential across each valve opening can be applied to transport fluid in and out of each of the plurality of zones, each of the plurality of chambers, each blister device, etc.

[0102] Referring now to FIG. 3B, a side view of an example cartridge 300B is shown, in accordance with present examples. The cartridge 300B may be the same as or similar to the cartridge 100 of FIGS. 1A and IB. Further, FIG. 3B may depict a second side of the cartridge 300A of FIG. 3A. That is, cartridge 300A may be the same cartridge as cartridges 00B.

[0103] The cartridge 300B includes a sample input chamber, a system composition stored in a blister device 106a, a first wash buffer stored in a blister device 106b, a second wash bufferAtty. Dkt. No.: 86357070stored in a blister device 106c, a PCA buffer 308 (e.g., a buffer used in a PCA amplification reaction) stored in a blister device 106d, and the second chamber 104. The cartridge 300B may also include membrane pinch valves 302, a pump fluidic interconnect 304, and membrane pinch valves 306.

[0104] Valves 302 and 306 may be specific types of valves used to restrict and permit fluid flow through the cartridge. For examples, valves 302 and / or 306 may be membrane valves, pinch valves, membrane pinch valves, etc. A membrane pinch valve may include a membrane (e.g., a flexible material, such as rubber) housed within a valve body. Pressure may be applied to the membrane, such as using air or water (e.g., air pumped via the pump fluidic interconnect 304), thereby causing the membrane to pinch together and collapse to restrict or prevent fluid flow through the valve. Releasing or removing the pressure on the membrane causes the fluid flow to resume or increase.

[0105] In various examples, the valves 302 and / or 306 may be membrane valves that are opened and closed by actuating a diaphragm toward and away from a valve seat, thereby allowing and preventing fluid flow. Similarly, in some examples the valves 302 and / or 306 are pinch valves that use a flexible tube or sleeve that is pinched, closing off the valve and preventing fluid flow. Valves 302 and 306 may also be one or more different types of valves, such as wax valves or volcano valves. For example, a wax valve be heated and cooled, causing wax to melt and subsequently solidify, to allow and prevent fluid flow. The pump fluidic interconnect 304 may be used to pump air, fluid, etc. through the cartridge 100. A pump may be, for example, a syringe pump, an air cylinder pump, a diaphragm pump, etc. Opening valves and pumping air through the cartridge 100 may extract liquid from a blister device 106.

[0106] For example, the pinch valves 302 and 306, and the pump fluidic interconnect 304 may be used to pump fluid to and from the blister devices 106 and the chambers of the cartridge. For example, a first wash buffer may be stored in the second blister device 106b. Upon rupturing of one or more seals of the second blister device 106b (e.g., by the rupturing members, due to actuation of one or more piercing elements of a piercing device), the pump fluidic interconnect 304 may pump air, fluid, etc. into the blister device 106b to cause the wash buffer to exit the blister device through the pierced seals. The wash buffer may flow through one or more channels and be pumped to a desired chamber (e.g.,. the first chamber 102), for example by controlling opening and closing of the membrane pinch valves 302 and 306 to direct the fluid to the correct chamber. Upon use of the fluid in the chamber, the pump fluidicAtty. Dkt. No.: 86357070interconnect 304 may be used to pump the used fluid from the chamber, through one or more channels (e.g., by controlling the membrane pinch valves 302 and 306), and back into the blister device 106b via the ruptured seals.

[0107] In some examples, each of the blister devices 106a-d of the present disclosure may enable reliable fluid flow in and out of the blister device 106. The ability to enable fluid flow from the blister device 106, to a chamber or other location within the cartridge 100, and back to the blister device 106 may allow the chamber to have multiple functions. For example, because the fluid can exit the chamber and reenter the blister device 106 after the fluid has been used in the chamber, additional processes or functions can be performed in the chamber that may have otherwise been unable to be performed if the fluid were to remain in the chamber. For example, lysing and hybridization may occur in a first chamber 102. The blister device 106a may deliver a system composition to the first chamber 102 to facilitate hybridization. The system composition may subsequently include a lysate that includes organisms or other material that should not be transported to a second chamber 104, in order to prevent contamination during amplification of nucleic acids of interest. As such, the system composition may be returned to the blister device 106a, leaving only the hybridized nucleic acids of interest in the first chamber 102. The first chamber 102 may then be able to further perform additional processes or functions, such as washing the hybridized nucleic acids (e.g., using first and / or second wash buffers dispensed from blister devices 106b and 106c, respectively), without potential contaminants found in the lysate or system composition that would otherwise remain in the first chamber 102. Similarly, the hybridized nucleic acids may be able to be transported to the second chamber 104 without introducing potential contaminants from the lysate into the second chamber 104 that may be amplified during an amplification reaction.

[0108] Additionally, by permitting fluid to flow back into a blister device 106 in which the fluid was originally stored, the function of the blister device 106 may be modified. For example, the blister device 106 may initially be used to store a single type of fluid (e.g., a system composition, a first wash buffer, or a second was buffer). After the stored fluid is released from the blister device 106, the fluid returned into the blister device 106 from a chamber of the cartridge may be different or have a different composition than the fluid initially stored. For example, the blister device 106a may store system composition, and the fluid returned to the blister device 106 may be or include system composition and a fluid containingAtty. Dkt. No.: 86357070a biological sample (e.g., saliva, blood, etc.). In this manner, in some examples, the blister devices 106 may initially function as storage for single fluids, and after dispensing the fluid, the blister device 106 may function as a waste chamber for a plurality of types of fluid, a fluid including multiple components, etc.

[0109] FIG. 4A depicts an example blister device 400, in accordance with present examples. The blister device 400 may be the same as or similar to the blister device 106 described with respect to FIGS. 1A and IB. Specifically, the blister device 400 includes two rupturing members 410 and 440 and two corresponding seals 412a and 412b (e.g., individually, seal 412, and together, seals 412). As illustrated by way of example in FIG. 4A, the example blister device 400 can include at least a first rupturing member 410 to open or close a seal 412a of the blister device 400 (e.g., a portion of the lidding foil 460 adjacent with the rupturing member 410), a metal coated polymer film 420, a reagent storage cavity 430, a second rupturing member 440 to open or close seal 412b of blister device 400 (e.g., a portion of the lidding foil 460 adjacent the rupturing member 440), a first fluid input-output area 450, the lidding foil 460 at least partially corresponding to the reagent storage cavity 430, and a second fluid input-output area 470. One or more chambers or zones of the cartridge 100 as discussed herein can comprise or include one or more blister devices similar to the blister device 400. This technical solution is not limited to blister devices discussed by way of example, and is not limited to exclude blister devices at any zone. The blister device 400 may be used to store liquid reagents in the cartridge 100. For example, the system composition and / or the wash buffer may be stored in a blister device 400. The blister device 400 may be attached, coupled, or otherwise affixed to the cartridge 100. The blister device 400 can provide a technical improvement to achieve bidirectional flow between and through zones of a cartridge as discussed herein.

[0110] As shown in FIG. 4A, the blister device 400 comprises rupturing members 410 and 440 that can be actuated to open the seals 412a and 412b, respectively. The rupturing members 410 and 440 may be integrated into the metal coated polymer film 420. In various examples, the rupturing members 410 and 440 may be used to rupture one-time open seals (e.g., seals 412). One-time open seals 412 may minimize water loss out of the storage cavity 430 through the closed or sealed rupturing members 410 and 440. The rupturing members may allow a common pump (e.g., a syringe pump) to deliver the contents of the blister device 400 to the microfluidic network of the cartridge 100. For example, the fluid entering and exiting the blister device 400 may enter and / or exit one or both of the seals 412. Further, the seals 412 may allow the reagentsAtty. Dkt. No.: 86357070stored in the blister device 400 to return to the blister device 400 after use. For example, a blister device 400 may store a wash buffer. The wash buffer may exit the blister device 400 (e.g., through a seal 412a or 412b) for use in the first or second chamber 102 or 104 to wash nucleic acids of interest. After washing is complete, the wash buffer may reenter the blister device 400 through the seals 412a and / or 412b. Storing used liquid reagents in the original blister device 400 may reduce the use of additional waste chambers in or on the cartridge 100, which may reduce a cost of manufacturing the cartridge 100 and / or may reduce a size of the cartridge 100. As such, the blister device 400 may additionally function as a waste chamber to store a used or exhausted liquid reagent.[OHl] As described above, the blister device 400 may include one or more seals 412. The seals 412 may be one time open seals. The opening of the seals 412 may allow a pump of the cartridge to deliver the reagents stored in a chamber or cavity 430 of the blister device to one or more locations of the cartridge. The seals may also allow the reagents to return to the chamber after use of the reagents. For example, once the seals 412 are opened, pumps and / or valves connected to the seals 412 and / or input-output areas 450 and 470 may facilitate recirculation of the fluid back into the blister device 400 after use. For example, the blister device 400 may store a wash buffer. The seals 412 may be opened to cause the wash buffer to exit the blister device 400 and be transported to a first chamber 102 for use in a hybridization reaction occurring in the first chamber 102. After washing with the wash buffer occurs, flow of the wash buffer may be reversed (e.g., by opening and closing particular valves in the cartridge 100), and the wash buffer may be returned to the blister device 400. Returning the fluid back to a blister device 400 may reduce the size of the cartridge 100, as waste chambers to store used fluids may be reduced and / or eliminated, since the blister device 400 may act as a waste chamber.

[0112] Further, enabling fluid flow from the blister device 400, to a chamber within the cartridge 100, and back to the blister device 400 may allow the chamber receiving the fluid to have multiple functions. For example, lysing and hybridization may occur in a first chamber 102. The seals 412a and / or 412b of the blister device 400 may be pierced by the rupturing members 410 and 440, respectively, causing a fluid (e.g., system composition) to exit the storage cavity 430 via the input-output areas 450 and / or 470 and be delivered to the first chamber 102 to facilitate hybridization. In the first chamber, after lysing and hybridization, the system composition may subsequently include a lysate that includes organisms or otherAtty. Dkt. No.: 86357070material that should not be transported to a second chamber 104, in order to prevent contamination during amplification of nucleic acids of interest. As such, the system composition may be returned to the blister device 400. For example, one or more pumps may pump the fluid back to the blister device 400 so the fluid reenters the storage chamber 430 via the input-output areas 450 and / or 470. The first chamber 102 may no longer include any fluid, and may be able to further perform additional processes or functions, such as washing the hybridized nucleic acids (e.g., using first and / or second wash buffers dispensed from additional blister devices), without potential contaminants found in the lysate or system composition that would otherwise remain in the first chamber 102. Similarly, the hybridized nucleic acids may be able to be transported to the second chamber 104 without introducing potential contaminants from the lysate into the second chamber 104 that may be amplified during an amplification reaction. Further, the blister device 400 may function as a waste storage chamber after receiving the fluid that has been used in the first chamber 102 and recirculated to the blister device 400.

[0113] As will be described with respect to FIGS. 5 A and 5B, the rupturing members 410 and 440 may interface with an actuator of the instrument 150 to modulate a compression of the one or more rupturing members 410 and 440.

[0114] The blister device 400 may be sealed off from channels and chambers of the cartridge 100 by the rupturing members 410 and 440 and / or the unruptured seals 412. The rupturing members 410 and 440 may cover a first port (e.g., the seal 412a and / or the first fluid inputoutput area 450) when the rupturing member is in a non-ruptured state. The blister device 400 may be in fluid communication with the channels and the chambers of the cartridge through the first port and / or via the first fluid input-output area 450 when the rupturing member is in a ruptured state.

[0115] The blister device 400 may comprise a second port (e.g., the seal 412b and / or an area underneath the rupturing member 440 and / or the second input output area 470) and may be sealed-off from the channels and the chambers of the cartridge by the second rupturing member. The blister device 400 may be in fluid communication with the channels and the chambers of the cartridge through the second port and / or via the second fluid input-output area 470 when said the rupturing member is in a ruptured state.Atty. Dkt. No.: 86357070

[0116] The blister device 400 may enclose a storage chamber when the storage chamber is configured in hermetically sealed-off relation from the channels and / or when the cartridge of the present disclosure is in a non-activated state. The storage chamber is configured for open communication with at least one of the plurality of zones and / or detection chambers such that liquid may flow freely between channels. For example, the blister device 400 may, when ruptured, allow fluid to flow freely between the blister device 400 and the first chamber 102.

[0117] In some examples, a first channel can be sealed-off from the blister device 400 by the seal 412a covering a first port when the first seal 412a is in a non-ruptured state. The first channel can be in fluid communication with the blister device 400 through the first port when the first seal 412a is in a ruptured state.

[0118] In some examples, a second channel can be sealed-off from the blister device 400 by the seal 412b covering the second port when the second seal 412b is in a non-ruptured state. The second channel can be in fluid communication with the chamber through the second port when the second seal 412b is in a ruptured state.

[0119] The first and second seals 412a and 412b may be ruptured or opened by the first and second rupturing members 410 and 440, respectively, to bring the first and second channels into fluid communication with the storage chamber through the first and second ports of the blister device 400. Upon selectively piercing, by the first and second rupturing members 410 and 440, at least one of the first and second seals 412a and 412b of the blister device 400 and forming the opening therein, the desired reagent can be introduced through a corresponding one of the channels having an opened port.

[0120] FIG. 4B depicts an example blister device 455, in accordance with present examples. The blister device 455 may be the same as or similar to the blister device 106 described with respect to FIGS. 1 A and IB. Specifically, the blister device 455 includes a single (e.g., one) rupturing member and a corresponding seal. As illustrated by way of example in FIG. 4B, the example blister device 400 can include at least a first rupturing member 410 to open or close a seal 412a of the blister device 455 (e.g., a portion of the lidding foil 460 adjacent with the rupturing member 410), a metal coated polymer film 420, a reagent storage cavity 430, and a fluid output area 475, the lidding foil 460 at least partially corresponding to the reagent storage cavity 430.Atty. Dkt. No.: 86357070

[0121] The blister device 455 may be similar to the blister device 300 described above with respect to FIG. 4A and may possess similar properties and functionalities. However, the blister device 455 may be a single valve or single seal blister device. As shown by arrow 485, the rupturing member 410 may be actuated to rupture the seal 412a. In a single valve blister device, fluid may only output or exit from the blister device. That is, fluid may not be able to reenter the blister device 455 after transport to a chamber and use of the fluid. As shown by arrow 490, fluid flow may be in a single direction to dispense fluid from the reagent storage cavity 430. Further, the single valve blister device 455 may be ruptured or actuated to dispense stored contents (e.g., fluid), as shown by arrow 480.

[0122] FIGS. 4C, 4D, and 4E depict a detailed view of the rupturing members 410 and / or 440 of the blister devices 400 and 455 and the seals 412 of FIGS. 4A and 4B, according to some examples. As shown in FIG. 4A, a chamber between the rupturing members 410 and / or 440 and the seals 412a and 412b, respectively, may include first and second fluid input-output areas 450 and 470. In various examples, the rupturing members 410 and / or 440 may be actuated, compressed, or otherwise manipulated to open a seal 412 (also referred to as a “one-time open valve” or a “valve”) and permit fluid flow. However, over-travel of the rupturing members 410 and 440 may cause a pressure restriction when liquid attempts to move through the blister device 400 or 455 and / in and out of the blister device 400 or 455. FIG. 4C depicts the seal 412 of the blister device 400 or 455 prior to actuation or travel of the rupturing member 410. The rupturing member 410 and the first input-output area 450 of FIG. 4A are shown. However, the elements of FIGS. 4C, 4D, and 4E may be the same or similar for rupturing member 440 and area 470 of FIG. 4A and / or for rupturing member 410 and area 475 of FIG. 4B. As shown in FIG. 4C, the rupturing member 410 may be uncompressed, and the seal 412a may be unbroken. Specifically, the fluid input-output area 450 is sealed by the unruptured seal 412a, such that fluid cannot enter and exit the blister device. The fluid contained in the blister device may be stored in a chamber of the blister device and may enter and exit the blister device from the input output area 450 via a channel 414 (as shown in FIG. 4D). FIG. 4D shows the blister device 400 when the rupturing member 410 is not over traveled (e.g., the rupturing member 410 is only partially compressed). This may permit fluid to flow in and out of the input-output area 450 upon actuation of the rupturing member 410. FIG. 4E depicts the seal 412a of the blister device 400 after actuation, specifically after over-travel of the rupturing member 410. As shown in FIG. 4E, flow may be restricted due to over-travel of the rupturing member 410. For example, in FIG. 4E, the rupturing member 410 has over traveled to reduce a size of theAtty. Dkt. No.: 86357070input-output area 450, thus restricting fluid flow. As such, fluid may have difficulty traveling through the blister device 400 and to and from other components of the cartridge 100 via the channel 414.

[0123] FIG. 5A depicts an example blister system 500, in accordance with present examples. As illustrated by way of example in FIG. 5A, an example blister system 500 can include at least a blister device 502 and one or more actuators 510 having stoppers 520 to control actuation depth, a piercing element 530 to interface with a rupturing member 540, causing the rupturing member 540 to open a frangible seal of the blister device 502, an actuator 560, and an actuation direction 570. The blister device 502 may include rupturing members 540 and a reagent storage cavity 550. The rupturing members 540 may interface with the piercing element 530 to open a frangible seal of the blister device 502 (e.g., the seal 412 of FIGS. 4A-4E). In various examples, the blister device 502 may be located in or on the cartridge 100. The actuator 510 may be located in or on the instrument 150. The actuator 510 (and / or 560) may be positioned in the instrument 150 such that the actuator aligns with the rupturing members 540 of the blister device 502 to allow the rupturing member(s) to break one or more seals of the blister device 502. That is, the piercing element 530 may align with a rupturing member 540. As the actuator 560 moves toward the rupturing member 540, the piercing element 530 may have a geometry that matches and / or is complementary to the geometry of the rupturing member 540. As such, the piercing element 530 may be convex and fit into a cavity created by a concave nature of the rupturing member 540. In various examples, the piercing element 530 may be any geometry, such as spherical, semispherical, dome shaped, cubic, triangular etc. The piercing element 530 may not be sharp, in order to prevent rupturing the rupturing member 540. That is, the piercing element 530 should push or actuate the rupturing member 540 such that the rupturing member ruptures or opens a seal 412 of the blister device, without the rupturing member 540 itself being opened.

[0124] The blister device 400 or 455 can correspond at least partially in one or more of structure and operation to the blister device 502, and can include or couple to one or more of the actuator 510, the stoppers 520, or the actuator 560 by one or more of the piercing element 530 and the rupturing members 540 to operate the actuators 510 and 560 in the actuation direction 570. For example, the actuation direction 570 can correspond to a first direction of movement of the actuators 510 or 560 toward the rupturing members 540 according to a piercing operation of one or more rupturing members 540 to open one or more of the frangibleAtty. Dkt. No.: 86357070seals (e.g., the seals 412). For example, the actuation direction 570 can correspond to a second direction of movement of the actuators 510 or 560 away from the rupturing members 540 subsequent to a piercing operation to open one or more of the rupturing members 540. Various examples can include a blister device in accordance with this disclosure, such as (but not limited to) the examples of the blister devices depicted in FIGS. 4A-5B. The blister system 500 may be part of other devices (e.g., other cartridges and systems) that interface with other instruments and systems.

[0125] As discussed with respect to FIGS. 4A-4E, over-travel of the piercing elements (e.g., rupturing members) of the blister device 502 may cause flow restriction. The actuator 510 may prevent over constriction. As shown in FIGS. 5 A and 5B, the actuator 510 may include stoppers 520 and a piercing element 530. The stoppers 520 and the piercing element 530 may prevent over travel. For example, the stoppers 520 may extend further or be longer than the piercing element. Thus, the stoppers 520 may prevent the piercing element 530 from contacting the rupturing members 540 at too great a depth, thus causing flow restriction. In various examples, the piercing element 530 may extend past the stoppers 520 by a length of, for example, between 0.2mm to 0.9mm.

[0126] Referring now to FIG. 6A, a cross-sectional view 600 of a blister device and actuator in a non-actuated position is shown, in accordance with examples. As shown in FIG. 6A, the piercing device 152 may include a cavity that is configured to receive an actuator 158. The actuator 158 may be controlled by the controller 160 to move in two directions along the same axis (e.g., forward and backward, up and down, etc.). As shown, the seal 108 of the blister device 106 is not ruptured, as the actuator 158 has not been actuated to move the piercing device 152 such that the piercing element of the piercing device interfaces with a rupturing element of the blister device to cause the rupturing element to rupture the seal 108.

[0127] Referring now to FIG. 6B, a cross-sectional view 650 of a blister device and actuator in an actuated position is shown, in accordance with examples. As shown, relative to FIG. 6A, the actuator 158 has been actuated by the controller 160 to cause the piercing device 152 to move toward the blister seal 108 such that the piercing element 156 interfaces with the blister device 106. Specifically, the piercing element 156 may contact a rupturing member of the blister device 106 and cause the rupturing member to move with the piercing device 152 in the same direction as the actuator 158 and piercing device 152. The piercing device 152, the actuator 158, and the rupturing member of the blister device may stop moving upon contact ofAtty. Dkt. No.: 86357070the stoppers 154 with a surface of the blister device 106. The stoppers 154 and the piercing element 156 may have lengths relative to one another that allow the rupturing member to be actuated enough that the blister seal 108 is ruptured, thereby allowing fluid to enter and exit the blister device 106, without over-actuating the rupturing member to prevent fluid flow.

[0128] Referring now to FIG. 7A, a perspective view of a piercing device 700 is shown, in accordance with examples. As shown, the piercing device 700 includes a first end 702 and a second end 704. The first end 702 may include the stoppers 706a and 706b (e.g., individually, stopper 706, and together, stoppers 706), as well as a piercing element 708. As described herein, the piercing element 708 may extend out from the piercing device 700 at a greater distance than the stoppers 706a and 706b. The stoppers 706a and 706b may extend out from the piercing device 700 at the same length to facilitate even contact of the piercing element 708 with a rupturing member of a blister device. The second end 704 may include a cavity 710 configured to receive an actuator having a geometry corresponding to a geometry of the cavity 710.

[0129] Referring now to FIG. 7B, a first perspective view 750 of a plurality of the piercing device of FIG. 7A interfacing with a blister device 752 is shown, in accordance with examples. As shown in FIG. 7B, a first piercing device 700a and a second piercing device 700b may each be aligned with the same blister device 752. The first piercing device 700a may align and interface with a first blister seal 754a. The second piercing device 700b may align and interface with a second blister seal 754b. The first end 702 of the piercing devices 700 may interface with the first and second blister seals 754 (e.g., individually, blister seal 754, and together, blister seals 754). Specifically, the piercing element of the first end 702 may interface with a rupturing member of the blister device 752 to cause blister seals 754 to be ruptured and opened. Rupturing one or more of the seals 754 may permit fluid 756 to enter and / or exit the blister device 752. The fluid may enter and / or exit the blister device 752 by pumping air into the blister device 752 via the ruptured seal(s) 754.

[0130] Referring now to FIGS. 7C and 7D, side and perspective views of the piercing devices 700a and 700b are shown, according to an example. Specifically, FIG. 7C shows a side view 760 of the plurality of the piercing devices 700 of FIG. 7B interfacing with a blister device 752. FIG. 7D shows a perspective view 780 of the plurality of the piercing devices 700 of FIG. 7B interfacing with a blister device 752. Specifically, as shown in FIG. 7C, a piercing element 708 of each of the blister devices 700a and 700b may, upon actuation of the piercing devices 700 toward the blister device 752, contact a rupturing member of the blister device 752. TheAtty. Dkt. No.: 86357070geometry of the piercing element may match and / or be complementary with the geometry of the rupturing member such that the rupturing member can receive the piercing element 708. As shown, the piercing element 708 extends past the stoppers 706 to be able to move the rupturing member to open the seals 754, without over-actuating the rupturing members.

[0131] Referring now to FIG. 8, a diagram 800 showing a plurality of piercing devices 700 interfacing with a housing 802 is shown, in accordance with examples. Specifically, a first end 702 of the piercing device 700 interfaces with the housing 802. The housing 802 may be a barrier between the instrument 150 and the cartridge 100 of a diagnostic system. For example, the piercing devices 700 may be contained within the instrument 150. The housing 802 may include a plurality of cavities 804 that have dimensions corresponding to the dimensions of the first end 702 of the piercing device 700. In this way, the first end 702 of the piercing device 700 (e.g., the stoppers and the piercing element) may protrude through the cavity 804, past a distal (relative to the inside of the housing 802) surface of the housing 802. The first end 702 of the piercing device 700 may then be able to freely contact surfaces of blister devices 106. In various examples, when an actuator 158 actuates the piercing device 700 away from a blister device 106 (e.g., retracts the piercing device 700), the first end 702 of the piercing device may not extend past a distal surface of the housing 802. As such, the first end 702 may be positioned within the cavity 804 or completely within the instrument 150 such that none of the piercing device 700 extends past a proximal surface of the housing 802.

[0132] Referring now to FIG. 9A, a method 900 of sequentially opening two valves of a blister device is shown, in accordance with examples. The method 900 begins at process 902. At process 904, a force is applied to a piercer (e.g., the piercing device 152). The force may be a 35 N force. The force may be applied to the piercer by an actuator to cause the piercer to contact a first valve (e.g., valve 1 or a rupturing member of a blister device) with a 35 N force. The force may cause a first seal of the blister device to open (e.g., via the rupturing member of the blister device). At process 906, the piecer is retracted (e.g., via the actuator).

[0133] At process 908, a force is applied to the piercer against a second valve to cause the piercer to contact the second valve with a 35 N force. The force may cause a second seal of the blister device to open. At process 910, the piecer is retracted (e.g., via the actuator). At process 912, a positive and / or negative pressure is applied to the blister device to extract liquid from the blister device. The method 900 ends at process 914.Atty. Dkt. No.: 86357070

[0134] Referring now to FIG. 9B, a method 920 of opening two valves of a blister device in parallel is shown, in accordance with examples. The method 920 begins at process 922. At process 924, a force is applied to a piercer (or, in some examples, multiple piercers) against first and second valves of a blister device. The force may be, for example, a 35 N force. At process 926, the piercers are retracted from the valves. At process 928, a positive and / or negative pressure is applied to the blister device to extract liquid from the blister device.

[0135] Referring now to FIG. 9C, a method 940 of opening a single valve of a blister device is shown, in accordance with examples. The method 940 begins at process 942. At process 944, a force is applied to a piercer (e.g., the piercing device 152). The force may be a 35 N force. The force may be applied to the piercer by an actuator to cause the piercer to contact a first valve (e.g., valve 1 or a rupturing member of a blister device) with a 35 N force. At process 946, the piercer is retracted. At process 948, the blister device is crushed or otherwise actuated (e.g., squeezed, etc.) to extract liquid from the blister device. The method 940 ends at process 950.

[0136] FIG. 10A depicts an example system, in accordance with present implementations. As illustrated by way of example in FIG. 10 A, an example system 1000 A can include at least a diagnostic cartridge 1010, a diagnostic instrument 1020, and a dropper 1030 A. The diagnostic cartridge may be the same as or similar to the cartridge 100, and the diagnostic instrument 1020 may be the same as or similar to the instrument 150. Specifically, as will be described in greater detail herein, the cartridge may include a sample input chamber comprising a liquid port. For example, a biological sample may be inserted into the cartridge via the sample input chamber. The cartridge may include a liquid port via which liquid samples may be received.

[0137] The diagnostic cartridge 1010 can receive and interact with a sample fluid by one or more components thereof. For example, the diagnostic cartridge 1010 can include one or more portions corresponding to zones, chambers, channels, reservoirs, containers, or any combination thereof. Specifically, the diagnostic cartridge 1010 may include a plurality of zones. The plurality of zones may include an extraction zone having one or more extraction chambers and a detection zone having one or more detection chambers. Each zone of the plurality of zones may be in fluid communication with each other.

[0138] The diagnostic cartridge 1010 can include one or more contents corresponding to chemicals, biochemicals, liquids, solutions, powders, materials, or any combination thereof,Atty. Dkt. No.: 86357070that can be present at or transferable between one or more of portions of the diagnostic cartridge 1010. Such contents may be stored in one or more blister devices 106 located throughout the diagnostic cartridge 1010. The blister devices 106 may be pierced (e.g., by a piercing device 108) to allow fluid to flow to various locations (e.g., zones, chambers, etc.) within the diagnostic cartridge 1010 and, in some examples, return back to a blister device 106 from which the fluid was released. For example, a blister device 106 may store a wash buffer. The blister device 106 may be pierced to permit the wash buffer to flow out of the blister device to an extraction chamber to wash a lysed biological sample. Upon completion of the wash, the wash buffer may return to the blister device 106 to be stored until the diagnostic cartridge 106 is disposed.

[0139] The diagnostic cartridge 1010 can include one or more components that can interact with one or more corresponding components of the diagnostic instrument 1020. For example, the blister devices 106 may align with one or more piercing devices 108 located within the diagnostic instrument 1020 upon insertion of the diagnostic cartridge 1010 into the diagnostic instrument 1020. The piercing devices 108 can be actuated to cause the blister devices to be pierced so fluid can enter and exit the blister devices 106. As another example, the diagnostic cartridge 1010 can include a heating element located in each detection chamber of the one or more detection chambers that can be placed in contact with or proximate to a heating element of the diagnostic instrument 1020, to heat content of a portion of the diagnostic cartridge 1010. The portion of the cartridge 1010 may be heated via an electrical connection to activate the one or more heating elements of each of the one or more detection chambers of the diagnostic cartridge 1010. The diagnostic cartridge 1010 can have a structure corresponding to a rectangular shape of a size corresponding to a palm. The diagnostic cartridge 1010 can have a height greater than a width of the diagnostic cartridge 1010, and a depth greater than a height of the diagnostic cartridge 1010.

[0140] For example, the diagnostic cartridge 1010 can be at least partially insertable into the diagnostic instrument 1020. That is, the cartridge 1010 may interface with the instrument. The instrument 1020 can include a sensor configured to detect the state of the cartridge or its contents. For example, the instrument 1020 can detect whether the cartridge 1010 is fully inserted into the diagnostic instrument 1020 by an optical sensor or the like. For example, the instrument 1020 can detect whether one or more portions of the cartridge are filled or ready forAtty. Dkt. No.: 86357070performance of a diagnostic test, by one or more sensors configured to detect fill level of one or more portions.

[0141] Upon complete insertion of the diagnostic cartridge 1010 into the diagnostic instrument 1020, the locations of one or more blister devices within the diagnostic cartridge 1010 may align with the locations of one or more piercing devices within the diagnostic instrument 1020. For example, a piercing device may align with one or more blister seals of a blister device such that the piercing device is actuated only in a single direction (e.g., to contact the blister seal), as opposed to multiple directions (e.g., to move the piercing device to align with the blister seal and subsequently move the piercing device to contact the blister seal). The diagnostic instrument 1020 may also include one or more actuators to interface with the one or more piercing devices. The actuators may be controlled to cause the piercing devices to move within the instrument 1020. For example, responsive to a determination that the diagnostic cartridge 1010 is fully inserted into the diagnostic instrument 1020, and responsive to a determination that a particular fluid stored in a blister device is to be released and transported to a particular location of the cartridge, the actuator may actuate the piercing device to cause the blister seal of the blister device to be opened.

[0142] The diagnostic cartridge 1010 can couple with the dropper 1030 A via a sample input chamber disposed at a surface of the diagnostic cartridge 1010. The sample input chamber may include a liquid port to receive a liquid, such as the biological sample. The sample input chamber can be disposed at a top surface of the diagnostic cartridge 1010, when the diagnostic cartridge 1010 is oriented to be inserted into the diagnostic instrument 1020. For example, the cartridge is configured to couple to the instrument 1020 to provide a user interface presenting at least one of an indication of an amount of the sample fluid in the cartridge or a status of the diagnostic test performed by the cartridge. For example, the cartridge has a physical interface configured to couple the cartridge to a holding device configured to hold the cartridge upright during injection of the sample fluid.

[0143] The diagnostic instrument 1020 can interact with the diagnostic cartridge 1010 and can generate one or more indications corresponding to one or more interactions with the diagnostic cartridge 1010. The diagnostic instrument 1020 can include one or more electrical and electronic components to initiate, control, and / or stop one or more interactions, and to generate one or more indications. For example, the diagnostic instrument 1020 can include one or more sensor devices, motors, actuators, processors, displays, or any combination thereof. TheAtty. Dkt. No.: 86357070diagnostic instrument 1020 can include a receptacle having a width corresponding to a width of the diagnostic cartridge 1010, and a height corresponding to a height of the diagnostic cartridge 1010. The diagnostic instrument 1020 can include one or more logical or electronic devices including but not limited to integrated circuits, logic gates, flip flops, gate arrays, programmable gate arrays, and the like. One or more electrical, electronic, or like devices, or components associated with the diagnostic instrument 1020 can also be associated with, integrated with, integrable with, replaced by, supplemented by, complemented by, or the like, a system processor or any component thereof. For example, an interaction can correspond to one or more chemical, biochemical, electrical, or electrochemical reactions corresponding to identification of one or more chemicals or biochemicals. One or more interactions can result in one or more changes in electrical, optical, chemical, or other characteristics and / or properties inside the cartridge. Such characteristics and / or properties can be detected with one or more sensors to, for example, identify a component (e.g., a molecule or microorganism), to determine a state of the component, to detect the component’s presence, and / or to determine the component’s quantity.

[0144] The diagnostic instrument 1020 can include a system processor that can execute one or more instructions associated with the system 1000, according to any of the depictions 1000A-C of the system 1000. The system processor can include an electronic processor, an integrated circuit, or the like including one or more of digital logic, analog logic, digital sensors, analog sensors, communication buses, volatile memory, nonvolatile memory, and the like. The system processor can include, but is not limited to, at least one microcontroller unit (MCU), microprocessor unit (MPU), central processing unit (CPU), graphics processing unit (GPU), physics processing unit (PPU), embedded controller (EC), or the like. The system processor can include a memory operable to store or storing one or more instructions for operating components of the system processor and operating components operably coupled to the system processor. The one or more instructions can include at least one of firmware, software, hardware, operating systems, embedded operating systems, and the like. The system processor or the diagnostic instrument 1020 generally can include at least one communication bus controller to effect communication between the system processor and the other elements of the system 1000.

[0145] The dropper 1030 A can store contents and expel contents to the diagnostic cartridge 1010. For example, the dropper 1030A can have a cylindrical shape including an inlet at a firstAtty. Dkt. No.: 86357070end and an outlet at a second end. The dropper 1030 A can include a reservoir corresponding to the cylindrical shape. For example, the dropper 1030A can have a reservoir with a volume corresponding to a medical syringe. The inlet of the dropper 1030 can correspond to a cap that can be opened to allow filling of the reservoir with contents. The outlet of the dropper 1030 A can correspond to a nozzle. For example, the nozzle of the dropper 1030 A can have a shape that can be mated with the sample input chamber of the diagnostic cartridge 1010. The dropper 1030A can be in a state disconnected from or not mated with the diagnostic cartridge 1010. For example, the dropper 1030A can be in a state prior to or subsequent to filling of the diagnostic cartridge 1010 with the content of the dropper 1030 A.

[0146] FIG. 10B depicts an example system, in accordance with present implementations. As illustrated by way of example in FIG. 10B, an example system 1000B can include at least a dropper 1030B operated by a user 1040 according to a direction 1050. The dropper 1030B can correspond at least partially in one or more of structure and operation to the dropper 1030 A. For example, the dropper 1030B can be in a state corresponding to filling of the diagnostic cartridge 1010 with the content of the dropper 1030 A. The user 1040 can correspond to an individual operating one or more of the dropper 1030B, the diagnostic cartridge 1010, and the diagnostic instrument 1020. For example, the user 1040 can orient the dropper 1030B to align the sample input chamber of the diagnostic cartridge 1010 to face the outlet of the dropper 1030B. For example, the user 1040 can move one or more of the diagnostic cartridge 1010 and the dropper 1030B in the direction 1050 to mate the inlet of the diagnostic cartridge 1010 with the outlet of the dropper 1030B.

[0147] FIG. 10C depicts an example system, in accordance with present implementations. As illustrated by way of example in FIG. 10C, an example system 1000C can include at least a display device 1060. The display device 1060 can present one or more indications of one or more biochemical characteristics associated with a sample fluid, and can include an electronic display. An electronic display can include, for example, a liquid crystal display (LCD), a lightemitting diode (LED) display, an organic light-emitting diode (OLED) display, or the like. The display device 1060 can receive, for example, capacitive or resistive touch input. The display device 1060 can be housed at least partially within the diagnostic instrument 1020. The display device 1060 can present one or more indications via one or more user interfaces that can include one or more graphical presentations and graphical control affordances. For example, a control affordance can include a portion of a user interface configured to detect user input. ExampleAtty. Dkt. No.: 86357070I / O components thus include, without limitation, a touchscreen display, a keypad or keyboard, biometric sensors such as a fingerprint scanners, buttons, switches, computer mice, microphones (e.g., for voice inputs such as test commands (e.g., “begin test”), passcodes (e.g., passcode known to authorized user), and / or voice recognition (e.g., analysis of voice signature of a user to record identity and / or compare voice signature for authentication or identity confirmation), speakers (e.g., for status updates such as “test in progress” or “test complete” or for speaking instructions for how to use an instrument or cartridge such as “insert cartridge further”), and / or other input / output devices.

[0148] In various examples, the diagnostic cartridge 1010 may include one or more extraction chambers (e.g., extraction or first chambers 102), one or more detection chambers (e.g., detection or second chambers 104), and one or more blister devices 106 storing one or more reagents.

[0149] At least one of the one or more extraction chambers is a hybridization chamber to hybridize the one or more nucleic acids of interest with at least one capture oligonucleotide attached to one or more magnetic particles of the plurality of magnetic particles. Further, at least one of the one or more detection chambers is an amplification chamber and one or more heating elements of the amplification chamber is a foil to interact with an electrical connection of an instrument to provide heat modulation to amplify the one or more nucleic acids of interest that have been hybridized to the at least one capture oligonucleotide attached to one or more magnetic particles of the plurality of magnetic particles.

[0150] The diagnostic cartridge may include a transparent window in at least one detection chamber of the one or more detection chambers to allow an optical unit in communication with the at least one detection chamber to detect a plurality of amplification products indicative of a presence, absence, or amount of the plurality of amplified nucleic acids of interest.

[0151] The one or more extraction chambers may be used to lyse the biological sample to release one or more nucleic acids of interest from the biological sample. In various examples, one of the one or more extraction chambers may be a hybridization chamber to hybridize the one or more nucleic acids of interest with at least one capture oligonucleotide attached to one or more magnetic particles of the plurality of magnetic particles.

[0152] Each of the one or more detection chambers may include a heating element at side portion of the detection chamber. The heating element may include a plurality of layers. ForAtty. Dkt. No.: 86357070example, a layer of the heating element may be a foil. In various examples, the plurality of layers may further include a heat spreading element and / or an adhesive.

[0153] At least one of the one or more detection chambers may be an amplification chamber configured to amplify the nucleic acids of interest. One or more heating elements of the amplification chamber may be a foil to interact with an electrical connection of an instrument to provide heat modulation to amplify the one or more nucleic acids of interest that have been hybridized (e.g., in the extraction chambers 114) to the at least one capture oligonucleotide attached to one or more magnetic particles of the plurality of magnetic particles.

[0154] The cartridge may further include one or more blister devices. Each blister device may store reagents (e.g., the wash composition). Each of the one or more blister devices may include one or more one-time open valves to allow a pump of the cartridge to deliver the reagents stored in a chamber of the blister device to one or more locations of the cartridge. The valves may also allow the reagents to return to the chamber after use of the reagents. The one or more onetime open valves may interface with an actuator of an instrument configured to modulate travel of a piercing element to open a valve or seal.

[0155] The phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting. The use of “including,” “comprising,” “having,” “containing,” “involving,” “characterized by,” “characterized in that,” and variations thereof herein, is meant to encompass the items listed thereafter, equivalents thereof, and additional items, as well as alternate examples consisting of the items listed thereafter exclusively. In one example, the systems and methods described herein consist of one, each combination of more than one, or all of the described elements, acts, or components.

[0156] References to “or” may be construed as inclusive so that any terms described using “or” may indicate any of a single, more than one, and all of the described terms. References to at least one of a conjunctive list of terms may be construed as an inclusive OR to indicate any of a single, more than one, and all of the described terms. For example, a reference to “at least one of ‘A’ and ‘B’” can include only ‘A,’ only ‘B,’ as well as both ‘A’ and ‘B.’ Such references used in conjunction with "comprising" or other open terminology can include additional items. References to “is” or “are” may be construed as nonlimiting to the example or action referenced in connection with that term. The terms “is” or “are” or any tense or derivative thereof, are interchangeable and synonymous with "can be" as used herein, unless stated otherwise herein.Atty. Dkt. No.: 86357070

[0157] Directional indicators depicted herein are example directions to facilitate understanding of the examples discussed herein and are not limited to the directional indicators depicted herein. Any directional indicator depicted herein can be modified to the reverse direction or can be modified to include both the depicted direction and a direction reverse to the depicted direction, unless stated otherwise herein. While operations are depicted in the drawings in a particular order, such operations are not required to be performed in the particular order shown or in sequential order, and all illustrated operations are not required to be performed. Actions described herein can be performed in a different order. Where technical features in the drawings, detailed description or any claim are followed by reference signs, the reference signs have been included to increase the intelligibility of the drawings, detailed description, and claims. Accordingly, neither the reference signs nor their absence have any limiting effect on the scope of any clam elements.

[0158] The various ranges provided herein include the stated range and any value or sub-range within the stated range. Furthermore, when “about” is utilized to describe a value or percentage this includes, refers to, and / or encompasses variations (up to + / - ten %) from the stated value or percentage. In describing and claiming the examples disclosed herein, the singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise.

[0159] Although specific examples have been illustrated and described herein, a variety of alternate and / or equivalent examples may be substituted for the specific examples shown and described without departing from the scope of the present disclosure. This application is intended to cover any adaptations or variations of the specific examples discussed herein. For example, the method 200 may include additional operations not explicitly recited or may exclude certain recited operations in some examples. Various examples of the cartridge 100 or the instrument 150 may include additional components not explicitly recited, may exclude certain recited components, or may include the recited components in different relative positions than shown in the examples described above. Therefore, it is intended that the scope of this disclosure be limited only by the claims and the equivalents thereof.

Claims

Atty. Dkt. No.: 86357070WHAT IS CLAIMED IS:

1. A diagnostic system comprising:a cartridge comprising:one or more chambers; andone or more blister devices, each blister device to store a fluid to be dispensed to or from at least one of the one or more chambers, each blister device comprising:two or more blister seals, each blister seal covering a valve opening of the blister device until the blister seal is pierced; andtwo or more rupturing members, each rupturing member covering one of the two or more blister seals; andan instrument to interface with the cartridge, the instrument comprising:one or more piercing devices, each piercing device to interface with one of the one or more blister devices, each piercing device comprising:a piercing element to interface with the two or more rupturing members to cause the two or more rupturing members to pierce the two or more blister seals of the one of the one or more blister devices; andone or more stoppers to control a piercing depth of the piercing element.

2. The diagnostic system of claim 1 , wherein the instrument further comprises one or more actuators to actuate the one or more piercing devices to and from the one or more blister devices.

3. The diagnostic system of claim 1, wherein the one or more stoppers are positioned on a first end of each of the one or more piercing devices, and wherein the first end of each of the one or more piercing devices is positioned to interface with a cavity of a housing of the instrument to guide the piercing device to a corresponding blister device.

4. The diagnostic system of claim 1, wherein the piercing element delivers a force of less than or equal to 35 Newtons to each of the two or more rupturing members to cause each of the two or more rupturing members to pierce one of the two or more blister seals.

5. The diagnostic system of claim 1, wherein a geometry of the piercing element matches a geometry of a corresponding rupturing member of the one of the one or more blister devices.Atty. Dkt. No.: 863570706. The diagnostic system of claim 1, wherein the piercing element is actuated to cause the two or more rupturing members to pierce the two or more blister seals such that fluid is dispensed from the one of the one or more blister devices.

7. The diagnostic system of claim 1, wherein each of the one or more blister devices comprises a first rupturing member and a second rupturing member and the instrument comprises a first piercing device and a second piercing device,wherein the first and second piercing devices are configured to move the first rupturing member and the second rupturing member, respectively, to cause the first rupturing member and the second rupturing member to pierce a first blister seal and a second blister seal, respectively, of the one of the one or more blister devices, andwherein the first and second rupturing members pierce the first and second blister seals in parallel.

8. A diagnostic system comprising:a cartridge comprising:one or more chambers; andone or more blister devices, each blister device to store a fluid to be dispensed at least one of the one or more chambers, each blister device comprising:one or more blister seals; andone or more rupturing members, each rupturing member covering one of the one or more blister seals; andan instrument to interface with the cartridge, the instrument comprising:one or more piercing devices, each piercing device to interface with one of the one or more blister devices, each piercing device comprising:a piercing element to interface with the one or rupturing members to cause the one or more rupturing members to pierce the one or more blister seals of the one of the one or more blister devices; andone or more stoppers to control a piercing depth of the piercing element; andone or more actuators, each actuator to interface with at least one of the one or more piercing devices; andAtty. Dkt. No.: 86357070a controller comprising one or more memory devices storing instructions thereon that, when executed by one or more processors, cause the one or more processors to:actuate at least one of the one or more actuators to cause the at least one of the one or more piercing devices to move toward the one or more rupturing members of a corresponding blister device until the one or more stoppers on each of the one or more piercing devices contacts a surface of the corresponding blister device.

9. The diagnostic system of claim 8, wherein the instructions further cause the one or more processors to:determine that at least one of the one or more rupturing members has pierced the one or more blister seals; andresponsive to the determination, actuate the at least one of the one or more actuators to cause the at least one of the one or more piercing devices to move away from the one or more rupturing members of the corresponding blister device.

10. The diagnostic system of claim 8, wherein the at least one of the one or more piercing devices moves toward the one or more rupturing members using a first force, and wherein the instructions further cause the one or more processors to:determine that the one or more rupturing members of the one or more blister devices has not pierced the one or more blister seals; andresponsive to the determination, actuate the at least one of the one or more actuators to cause the at least one of the one or more piercing devices to move toward the one or more rupturing members of the one or more blister devices using a second force, the second force greater than the first force.

11. The diagnostic system of claim 8, wherein the one or more blister devices comprise a first rupturing member and a second rupturing member and the instrument comprises a first piercing device coupled to a first actuator and a second piercing device coupled to a second actuator, and wherein the first and second piercing devices are configured to move the first rupturing member and the second rupturing member, respectively, to cause the first rupturing member and the second rupturing member to pierce a first blister seal and a second blister seal, respectively, of the one of the one or more blister devices.Atty. Dkt. No.: 8635707012. The diagnostic system of claim 11, wherein the instructions further cause the one or more processors to:actuate, using the first actuator, the first piercing device toward the first rupturing member; andactuate, using the second actuator, the second piercing device toward the second blister rupturing member in parallel with the actuation of the first actuator.

13. The diagnostic system of claim 11, wherein the instructions further cause the one or more processors to:actuate, using the first actuator, the first piercing device toward the first blister seal during a first time period; andactuate, using the second actuator, the second piercing device toward the second blister seal during a second time period, the second time period occurring after the first time period.

14. The diagnostic system of claim 8, wherein the corresponding blister device comprises a first rupturing member and a second rupturing member, and wherein the instructions cause the one or more processors to:responsive to a determination that the one or more stoppers on each of the one or more piercing devices contacts a surface of the corresponding blister device surrounding the first rupturing member, actuate the at least one of the one or more actuators to cause the at least one of the one or more piercing devices to from a location corresponding to the first rupturing member toward a location corresponding to the second rupturing member; andactuate at least one of the one or more actuators to cause the at least one of the one or more piercing devices to move toward the second rupturing member until the one or more stoppers on each of the one or more piercing devices contacts a surface of the corresponding blister device surrounding the second rupturing member.

15. The diagnostic system of claim 8, wherein the one or more stoppers are positioned on a first end of the piercing device, and wherein the first end of each of the one or more piercing devices is positioned to interface with a cavity of a housing of the instrument to guide the piercing device to a corresponding blister device.

16. A method for piercing one or more blister seals of a blister device of a diagnostic cartridge, the blister device to store a liquid, the method comprising:Atty. Dkt. No.: 86357070responsive to a determination to dispense the liquid from the blister device, actuating an actuator for a first time, the actuator interfacing with an end of a piercing device, the actuating for the first time moving the piercing device toward a first rupturing member covering a first blister seal of the one or more blister seals of the blister device to cause a piercing element of the piercing device to move the first rupturing member toward the first blister seal;piercing the first blister seal with the first rupturing member based on the actuating of the actuator for the first time;responsive to detecting a stopper of the piercing device contacting a surface of the blister device, actuating the actuator for a second time, the actuating for the second time retracting the piercing device from the first rupturing member; andextracting the liquid from the pierced blister device to a chamber of the cartridge.

17. The method of claim 16, wherein the actuating for the first time moves the piercing device toward the first rupturing member using a first force, and wherein the method further comprises:determining that the first rupturing member has not pierced the first blister seal; and responsive to the determination, actuating the actuator for a second time to cause the piercing device to move toward the first rupturing member of the blister device using a second force, the second force greater than the first force.

18. The method of claim 16, wherein the actuator is a first actuator and the piercing device is a first piercing device, and wherein the method further comprises:actuating, using a second actuator, a second piercing device toward a second rupturing member of the blister device while the actuating the first actuator to move the first piercing device toward the first rupturing member.

19. The method of claim 16, wherein the actuator is a first actuator and the piercing device is a first piercing device, and wherein the method further comprises:actuating, using a second actuator, a second piercing device toward a second rupturing member of the one or more blister seals of the blister device subsequent to actuating the first actuator to move the first piercing device toward the first rupturing member.

20. The method of claim 16, wherein the method further comprises:Atty. Dkt. No.: 86357070responsive to actuating the actuator for a second time, actuating the actuator for a third time, actuating the actuator for the third time moving the actuator from a location corresponding to the first rupturing member to a location corresponding to a second rupturing member of the blister device;actuating an actuator for a fourth time, the actuating for the fourth time moving the piercing device toward the second rupturing member of the blister device to cause a piercing element of the piercing device to move the second rupturing member toward the second blister seal;piercing the second blister seal with the second rupturing member based on the actuating of the actuator for the fourth time; andresponsive to detecting the stopper of the piercing device contacting a surface of the blister device, actuating the actuator for a fifth time, the actuating for the fifth time retracting the piercing device from the second rupturing member.